Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing—study on P300 and mismatch negativity in healthy volunteers
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing—study on P300 and mismatch negativity in healthy volunteers
Authors
Keywords
Psilocybin, Model of psychosis, Human, ERP, MMN, P300
Journal
PSYCHOPHARMACOLOGY
Volume 235, Issue 2, Pages 491-503
Publisher
Springer Nature
Online
2018-01-05
DOI
10.1007/s00213-017-4807-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neural mechanisms of mismatch negativity dysfunction in schizophrenia
- (2017) M Lee et al. MOLECULAR PSYCHIATRY
- LSD modulates effective connectivity and neural adaptation mechanisms in an auditory oddball paradigm
- (2017) Christopher Timmermann et al. NEUROPHARMACOLOGY
- Sex differences and serotonergic mechanisms in the behavioural effects of psilocin
- (2016) Filip Tylš et al. BEHAVIOURAL PHARMACOLOGY
- A Meta-Analysis of Mismatch Negativity in Schizophrenia: From Clinical Risk to Disease Specificity and Progression
- (2016) Molly A. Erickson et al. BIOLOGICAL PSYCHIATRY
- Mismatch Negativity in First-Episode Schizophrenia
- (2016) Sarah M. Haigh et al. CLINICAL EEG AND NEUROSCIENCE
- The effects of ketamine on the mismatch negativity (MMN) in humans – A meta-analysis
- (2016) Timm Rosburg et al. CLINICAL NEUROPHYSIOLOGY
- Neural correlates of the LSD experience revealed by multimodal neuroimaging
- (2016) Robin L. Carhart-Harris et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Meta-analytic Review of Auditory Event-Related Potential Components as Endophenotypes for Schizophrenia: Perspectives From First-Degree Relatives
- (2016) Holly A. Earls et al. SCHIZOPHRENIA BULLETIN
- Pitch and Duration Mismatch Negativity and Premorbid Intellect in the First Hospitalized Schizophrenia Spectrum
- (2016) Dean F. Salisbury et al. SCHIZOPHRENIA BULLETIN
- Lysergic Acid Diethylamide and Psilocybin Revisited
- (2015) Mark A. Geyer BIOLOGICAL PSYCHIATRY
- Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers
- (2015) Rainer Kraehenmann et al. BIOLOGICAL PSYCHIATRY
- Auditory dysfunction in schizophrenia: integrating clinical and basic features
- (2015) Daniel C. Javitt et al. NATURE REVIEWS NEUROSCIENCE
- Clinical high risk and first episode schizophrenia: Auditory event-related potentials
- (2015) Elisabetta C. del Re et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Mismatch Negativity (MMN) as an Index of Cognitive Dysfunction
- (2014) Risto Näätänen et al. BRAIN TOPOGRAPHY
- The entropic brain: a theory of conscious states informed by neuroimaging research with psychedelic drugs
- (2014) Robin L. Carhart-Harris et al. Frontiers in Human Neuroscience
- P300 Development across the Lifespan: A Systematic Review and Meta-Analysis
- (2014) Rik van Dinteren et al. PLoS One
- P300 Aberration in First-Episode Schizophrenia Patients: A Meta-Analysis
- (2014) Yao-qin Qiu et al. PLoS One
- The Effect of Psilocin on Memory Acquisition, Retrieval, and Consolidation in the Rat
- (2014) Lukas Rambousek et al. Frontiers in Behavioral Neuroscience
- Bridging disparate symptoms of schizophrenia: a triple network dysfunction theory
- (2014) Tereza Nekovarova et al. Frontiers in Behavioral Neuroscience
- Psilocybin – Summary of knowledge and new perspectives
- (2013) Filip Tylš et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Broadband Cortical Desynchronization Underlies the Human Psychedelic State
- (2013) S. D. Muthukumaraswamy et al. JOURNAL OF NEUROSCIENCE
- Activation of Serotonin 2A Receptors Underlies the Psilocybin-Induced Effects on Oscillations, N170 Visual-Evoked Potentials, and Visual Hallucinations
- (2013) M. Kometer et al. JOURNAL OF NEUROSCIENCE
- Reviewing the ketamine model for schizophrenia
- (2013) Joel Frohlich et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Neural Basis for the Ability of Atypical Antipsychotic Drugs to Improve Cognition in Schizophrenia
- (2013) Tomiki Sumiyoshi et al. Frontiers in Behavioral Neuroscience
- Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors
- (2012) Michael Kometer et al. BIOLOGICAL PSYCHIATRY
- Functional Connectivity Measures After Psilocybin Inform a Novel Hypothesis of Early Psychosis
- (2012) Robin L. Carhart-Harris et al. SCHIZOPHRENIA BULLETIN
- Glutamatergic Modulation of Auditory Information Processing in the Human Brain
- (2011) Handan Gunduz-Bruce et al. BIOLOGICAL PSYCHIATRY
- The acute effects of d-amphetamine and d-methamphetamine on ERP components in humans
- (2011) B. Silber et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Ketamine effects on brain function — Simultaneous fMRI/EEG during a visual oddball task
- (2011) Francesco Musso et al. NEUROIMAGE
- Mismatch Negativity Encoding of Prediction Errors Predicts S-ketamine-Induced Cognitive Impairments
- (2011) André Schmidt et al. NEUROPSYCHOPHARMACOLOGY
- Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers
- (2011) Boris B Quednow et al. NEUROPSYCHOPHARMACOLOGY
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
- (2011) Roland R. Griffiths et al. PSYCHOPHARMACOLOGY
- Dexamphetamine-induced reduction of P3a and P3b in healthy participants
- (2010) Matthew A Albrecht et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Sex differences in the effects of N,N-diethyllysergamide (LSD) on behavioural activity and prepulse inhibition
- (2010) Tomáš Páleníček et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Auditory and visual P300 reflecting cognitive improvement in patients with schizophrenia with quetiapine: A pilot study
- (2010) E-Jin Park et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Relationships between sensory “gating out” and sensory “gating in” of auditory evoked potentials in schizophrenia: A pilot study
- (2010) Klevest Gjini et al. SCHIZOPHRENIA RESEARCH
- Effects of Quetiapine on Cognitive Functions in Schizophrenic Patients: A Preliminary Single-trial ERP Analysis
- (2009) Y. Zhang et al. PHARMACOPSYCHIATRY
- Sensory Gating in Schizophrenia: P50 and N100 Gating in Antipsychotic-Free Subjects at Risk, First-Episode, and Chronic Patients
- (2008) Anke Brockhaus-Dumke et al. BIOLOGICAL PSYCHIATRY
- Effects of an NMDA-receptor antagonist MK-801 on an MMN-like response recorded in anesthetized rats
- (2008) Dmitry Tikhonravov et al. BRAIN RESEARCH
- Deviance-elicited Changes in Event-related Potentials are Attenuated by Ketamine in Mice
- (2008) Richard S. Ehrlichman et al. JOURNAL OF COGNITIVE NEUROSCIENCE
- Human hallucinogen research: guidelines for safety
- (2008) MW Johnson et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Computational models of schizophrenia and dopamine modulation in the prefrontal cortex
- (2008) Edmund T. Rolls et al. NATURE REVIEWS NEUROSCIENCE
- Reduced auditory evoked potential component N100 in schizophrenia — A critical review
- (2008) Timm Rosburg et al. PSYCHIATRY RESEARCH
- Mismatch negativity generation in the human 5HT2A agonist and NMDA antagonist model of psychosis
- (2008) Karsten Heekeren et al. PSYCHOPHARMACOLOGY
- Serotonin research: contributions to understanding psychoses
- (2008) M GEYER et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started